• T7 RNA Polymerase for Translational RNA Workflows

  2026-09-02

  T7 RNA Polymerase converts promoter-defined DNA into targeted RNA for assays spanning translation, RNAi, probe generation, and preclinical RNA delivery. This guide connects practical transcription setup and troubleshooting with an inhaled RNA immunotherapy study, while separating enzyme-enabled workflow choices from claims demonstrated in vivo.

• TH287: Designing Oxidative DNA Damage Assays

  2026-09-01

  TH287, a highly potent MTH1 inhibitor, offers a precise way to study oxidized nucleotide stress and cancer-cell responses. This article focuses on temporal assay design, radiation-combination logic, controls, and interpretation beyond simple endpoint viability.

• NU7441 (KU-57788) DNA-PK Inhibitor Guide

  2026-09-01

  NU7441, also called KU-57788, is a selective ATP-competitive DNA-PK inhibitor with reported nanomolar potency. Its DNA repair research uses include mechanistic studies, cancer-cell chemosensitization, and cell cycle arrest assays, while its formulation and dosing parameters require model-specific optimization.

• MLN4924 HCl Salt: Neddylation to Translation

  2026-08-31

  MLN4924 HCl salt is a selective NEDD8-activating enzyme inhibitor for connecting cullin-RING ligase biology with translational questions in cancer, cell-cycle control, and virus-induced inflammation. This thought-leadership guide links NAE mechanism, RIPK3 degradation research, experimental validation, and strategic workflow design without overstating what the current evidence proves.

• YC-1: Practical Hypoxia Research Workflow

  2026-08-31

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol provides a research tool for studying HIF-1α regulation, soluble guanylyl cyclase signaling, and related cancer-biology endpoints. It is appropriate for controlled in vitro or in vivo research workflows, but not for diagnostic, therapeutic, or clinical use, and the dossier does not provide model-specific dosing or directly matched paper evidence.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-08-30

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody detects goat IgG primary antibodies in fluorescence-based ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used as a general secondary reagent for non-goat primaries or assumed suitable for live-cell or nonfluorescent detection without compatibility testing.

• NU7441 (KU-57788): From Probe to Translation

  2026-08-29

  NU7441 (KU-57788) offers translational researchers a precise way to interrogate DNA-PK-dependent DNA repair, treatment sensitization, and cell-cycle behavior. This thought-leadership perspective moves beyond catalog specifications to show how mechanistic controls, pharmacologic context, and assay design can turn an ATP-competitive DNA-PK inhibitor into a stronger decision-making tool for DNA repair research and oncology research.

• Tropifexor Protects the Neonatal Intestinal Barrier

  2026-08-28

  A 2025 FASEB Journal study shows that the FXR agonist Tropifexor, also known as LJN452, reduces parenteral nutrition-associated intestinal injury in neonatal piglets and improves barrier integrity in pediatric patient-derived organoids. The work connects in vivo physiology, transcriptomics, EPCAM regulation, and organoid validation to define a potentially context-dependent FXR signaling pathway modulator for intestinal epithelial barrier function research.

• 4-Phenylbutyric Acid in ER Stress Research

  2026-08-28

  4-Phenylbutyric acid, or 4-PBA, is a phenyl-substituted butanoic acid used as a chemical chaperone in endoplasmic reticulum stress research. Its value is mechanistic: it can support protein-folding studies, but the PFOS kidney-cell study cited here does not establish 4-PBA efficacy in that model.

• 3-Aminobenzamide: A PARP Inhibition Assay Compass

  2026-08-27

  3-Aminobenzamide (PARP-IN-1) is a practical tool for dissecting stress-responsive ADP-ribosylation. This article connects its cellular activity to rigorous assay design, vascular and renal models, and the limitations revealed by coronavirus host-response research.

• DIDS: Workflow Guide for Metastasis Assays

  2026-08-27

  DIDS links chloride-transport pharmacology with practical near-death survivor, migration, and cytokine assays. This guide shows how to use it as a carefully controlled mechanistic perturbation while avoiding solubility, specificity, and interpretation errors.

• G-1: Selective GPR30 Agonist Workflows

  2026-08-26

  G-1 provides a focused way to separate rapid GPR30 signaling from classical estrogen-receptor effects in immune, cardiovascular, and breast cancer models. This guide translates published findings into practical assay design, dosing, controls, and troubleshooting steps.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-08-26

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a practical two-color method for distinguishing viable, early apoptotic, late apoptotic, and membrane-compromised cells. It is suitable for research flow cytometry or fluorescence microscopy, but it should not be used as a stand-alone diagnostic test or as proof of a specific apoptotic mechanism.

• BPEP-EM Hydrogel for Bacterial Keratitis

  2026-08-25

  Zheng and colleagues developed a thermosensitive BPOSS–poly-PEG/PPG urethane hydrogel that improves erythromycin solubility, ocular retention, and antibacterial performance in a mouse model of Staphylococcus aureus keratitis. The study provides a formulation strategy for addressing rapid tear-mediated clearance while emphasizing the need to validate ocular compatibility alongside therapeutic efficacy.

• Cell Cycle Assay Kit for CRC Research

  2026-08-25

  Use PI-based DNA-content profiling to connect treatment response with cell-cycle arrest, apoptotic loss, and population quality in colorectal cancer models. This workflow shows how the Cell Cycle Assay Kit (Catalog No. K2263) can strengthen CGF mechanism studies while providing practical controls and troubleshooting guidance.

8534 records 3/569 page Previous Next 12345 下5页 Last page